Novartis Vaccines, Germany

Faithful+Gould provided project control services for the Marburg Site Development (MARS), a development worth around €170m, one of the largest of its type in Germany. The development is a green field manufacturing plant for the production of Rabies and TBE (tick borne encephalitis) vaccines, and a new quality control building. The vaccines, adjuvants, media and buffer preparation are all produced in a state-of-the-art 'clean room' environment.

The plant uses the latest plant automation and Manufacturing Execution System (MES) technologies. We provided project control services to the client during the design, construction and qualification stages, including: Initial assessment report, cost management and reporting, scheduling, commercial management.

Related expert